切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2025, Vol. 11 ›› Issue (03) : 288 -293. doi: 10.3877/cma.j.issn.2096-1537.2025.03.011

综述

血管活性药物评分在脓毒症预后中的评价作用
侯舒雅, 李文雄, 黄立锋()   
  1. 100020 北京,首都医科大学附属北京朝阳医院重症医学科
  • 收稿日期:2025-02-28 出版日期:2025-08-28
  • 通信作者: 黄立锋
  • 基金资助:
    国家自然科学基金面上项目(81372042); 北京市自然科学基金面上项目(7222065); 北京朝阳医院多学科临床研究创新团队重点项目(CYDXK202212)

Predictive value of vasoactive-inotropic score in sepsis prognosis

Shuya Hou, Wenxiong Li, Lifeng Huang()   

  1. Department of Critical Care Medicine, Beijing Chaoyang Hospital Affiliated to Capital Medical University, Beijing 100020, China
  • Received:2025-02-28 Published:2025-08-28
  • Corresponding author: Lifeng Huang
引用本文:

侯舒雅, 李文雄, 黄立锋. 血管活性药物评分在脓毒症预后中的评价作用[J/OL]. 中华重症医学电子杂志, 2025, 11(03): 288-293.

Shuya Hou, Wenxiong Li, Lifeng Huang. Predictive value of vasoactive-inotropic score in sepsis prognosis[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2025, 11(03): 288-293.

血管活性药物评分(VIS)通过等效量化不同种类、不同剂量的血管活性药物,可实时、动态、直接、客观地评估患者病情严重程度、药物支持力度及血流动力学状态。近年来该评分在临床中得到了越来越广泛的应用,尤其是在脓毒症的治疗过程中。本文通过回顾归纳VIS评分与脓毒症的相关研究,旨在阐明VIS评分对脓毒症预后的评价作用,以期帮助临床医师尽早识别脓毒症患者病情严重程度,评估其预后并指导临床治疗。

The vasoactive-inotropic score (VIS) was developed to equivalently quantify the dosage of various vasoactive and inotropic agents, enabling a real-time, dynamic, direct, and objective assessment of disease severity, the intensity of pharmacological support, and hemodynamic status. In recent years, the VIS has been increasingly applied in clinical practice, particularly in the management of sepsis. This article reviews and synthesizes current evidence on the association between the VIS and the outcomes in sepsis, aiming to elucidate the prognostic value of the VIS. By consolidating this knowledge, this review seeks to assist clinicians in early identification of disease severity, prognostic stratification, and guidance of therapeutic strategies for sepsis patients.

1
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.
2
Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study [J]. Lancet, 2020, 395(10219): 200-211.
3
Fleischmann-Struzek C, Mellhammar L, Rose N, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis [J]. Intensive Care Med, 2020, 46(8): 1552-1562.
4
De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock [J]. N Engl J Med, 2010, 362(9): 779-789.
5
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 [J]. Crit Care Med, 2021, 49(11): e1063-e1143.
6
Ahn C, Yu G, Shin TG, et al. Comparison of early and late norepinephrine administration in patients with septic shock: a systematic review and meta-analysis [J]. Chest, 2024, 166(6): 1417-1430.
7
Xiang H, Zhao Y, Ma S, et al. Dose-related effects of norepinephrine on early-stage endotoxemic shock in a swine model [J]. J Intensive Med, 2023, 3(4): 335-344.
8
De Backer D, Pinsky M. Norepinephrine improves cardiac function during septic shock, but why? [J]. Br J Anaesth, 2018, 120(3): 421-424.
9
Wilson M, Schafer K, Goldschmidt E, et al. Norepinephrine-induced peripheral ischemia leading to gangrene: a case series [J]. Adv Skin Wound Care, 2021, 34(5): 273-277.
10
Gaies MG, Gurney JG, Yen AH, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass [J]. Pediatr Crit Care Med, 2010, 11(2): 234-238.
11
Wernovsky G, Wypij D, Jonas RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest [J]. Circulation, 1995, 92(8): 2226-2235.
12
Favia I, Vitale V, Ricci Z. The vasoactive-inotropic score and levosimendan: time for LVIS? [J]. J Cardiothorac Vasc Anesth, 2013, 27(2): e15-e16.
13
Nguyen HV, Havalad V, Aponte-Patel L, et al. Temporary biventricular pacing decreases the vasoactive-inotropic score after cardiac surgery: a substudy of a randomized clinical trial [J]. J Thorac Cardiovasc Surg, 2013, 146(2): 296-301.
14
Maeda T, Toda K, Kamei M, et al. Impact of preoperative extracorporeal membrane oxygenation on vasoactive inotrope score after implantation of left ventricular assist device [J]. Springerplus, 2015, 4: 821.
15
Yamazaki Y, Oba K, Matsui Y, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in adults after cardiac surgery with cardiopulmonary bypass [J]. J Anesth, 2018, 32(2): 167-173.
16
Landoni G, Lomivorotov VV, Alvaro G, et al. Levosimendan for hemodynamic support after cardiac surgery [J]. N Engl J Med, 2017, 376(21): 2021-2031.
17
Belletti A, Lerose CC, Zangrillo A, et al. Vasoactive-inotropic score: evolution, clinical utility, and pitfalls [J]. J Cardiothorac Vasc Anesth, 2021, 35(10): 3067-3077.
18
Patel BM, Chittock DR, Russell JA, et al. Beneficial effects of short-term vasopressin infusion during severe septic shock [J]. Anesthesiology, 2002, 96(3): 576-582.
19
Goradia S, Sardaneh AA, Narayan SW, et al. Vasopressor dose equivalence: a scoping review and suggested formula [J]. J Crit Care, 2021, 61: 233-240.
20
Kotani Y, Di Gioia A, Landoni G, et al. An updated "norepinephrine equivalent" score in intensive care as a marker of shock severity [J]. Crit Care, 2023, 27(1): 29.
21
Li W, Wang Y, Abuduaini B, et al. Prognostic evaluation of the norepinephrine equivalent score and the vasoactive-inotropic score in patients with sepsis and septic shock: a retrospective cohort study [J]. Front Cardiovasc Med, 2024, 11: 1415769.
22
Dauhan AC, Lubis AD, Lubis M. Vasoactive-inotropic score for early detection and mortality prediction of sepsis in children [J]. Indones Biomed J, 2021, 13(1): 34-39.
23
Pudjiadi AH, Pramesti DL, Pardede SO, et al. Validation of the vasoactive-inotropic score in predicting pediatric septic shock mortality: a retrospective cohort study [J]. Int J Crit Illn Inj Sci, 2021, 11(3): 117-122.
24
McIntosh AM, Tong S, Deakyne SJ, et al. Validation of the vasoactive-inotropic score in pediatric sepsis [J]. Pediatr Crit Care Med, 2017, 18(8): 750-757.
25
Kallekkattu D, Rameshkumar R, Chidambaram M, et al. Threshold of inotropic score and vasoactive–inotropic score for predicting mortality in pediatric septic shock [J]. Indian J Pediatr, 2022, 89(5): 432-437.
26
Çeleğen M, Çeleğen K. Is vasoactive-inotropic score associated with early lactate clearance a predictive outcome of children with septic shock? [J]. Turk J Pediatr, 2022, 64(4): 708-716.
27
Ninmer EK, Charlton JR, Spaeder MC. Risk factors for sepsis-associated acute kidney injury in the PICU: a retrospective cohort study [J]. Pediatr Crit Care Med, 2022, 23(7): e366-e370.
28
Kara I, Sargin M, Bayraktar , et al. The use of vasoactive-inotropic score in adult patients with septic shock in intensive care [J]. J Med Surg Intensive Care Med‌‌, 2019, 10: 23-30.
29
Song J, Cho H, Park DW, et al. Vasoactive-inotropic score as an early predictor of mortality in adult patients with sepsis [J]. J Clin Med, 2021, 10(3): 495.
30
Ning YL, Sun C, Xu XH, et al. Tendency of dynamic vasoactive and inotropic medications data as a robust predictor of mortality in patients with septic shock: an analysis of the MIMIC-Ⅳ database [J]. Front Cardiovasc Med, 2023, 10: 1126888.
31
Xiao S, Zhuang Q, Li Y, et al. Longitudinal vasoactive inotrope score trajectories and their prognostic significance in critically ill sepsis patients: a retrospective cohort analysis [J]. Clin Ther, 2024, 46(9): 711-716.
32
Chen Y, Jiang H, Wei Y, et al. Blood pressure response index and clinical outcomes in patients with septic shock: a multicenter cohort study [J]. EBioMedicine, 2024, 106: 105257.
[1] 罗兵, 董凤群, 牛艺臻, 王锟, 程志华, 刘宏强. 胎儿超声心动图在单纯性肺动脉瓣狭窄及预后评估中的价值[J/OL]. 中华医学超声杂志(电子版), 2025, 22(08): 740-747.
[2] 毛俊, 蔡兆伦, 尹晓南, 沈朝勇, 张波. 影像组学预测模型在胃肠间质瘤诊断及预后中的研究进展[J/OL]. 中华普通外科学文献(电子版), 2025, 19(06): 421-425.
[3] 贺雅莉, 黄丽, 杨培娟. 功能保留手术在低位直肠癌治疗中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 701-704.
[4] 田超, 黄若曦, 蒋茂林, 谢崇伟, 刁鹏飞, 钟苏权, 陈东, 王航涛, 陈桂柳, 陈虞娟, 李国良. 不同亚型前列腺癌新辅助化疗后盆腔淋巴结转移的风险因素及时间分布[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(06): 727-735.
[5] 许志翱, 顾丽萍, 曹敏, 宣梦馨, 李艳婷, 赵丽亭. 基于加速康复外科和预康复模式对老年肺癌围术期多维度管理干预及预后的影响[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(06): 979-984.
[6] 刘建鹏, 严丽燕, 冯少婷, 黄鹏, 梁开丽, 方鸿飞. D-二聚体、肌钙蛋白及氨基末端脑利钠肽前体在急性肺栓塞预后中的临床意义研究[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(06): 1019-1022.
[7] 吴蓉, 蔡喆燚, 黄运华, 乐金海, 张萍, 陈献, 易琼. 跨肺驱动压导向呼气末正压通气对急性呼吸窘迫综合征患者肺功能及预后的影响[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(06): 866-871.
[8] 陈晞, 杜海鸥, 张毛为, 刘亚南, 孙宜田, 王倩格, 刘琦, 陈碧. 抗合成酶综合征发生快速进展型间质性肺病的危险因素和预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(06): 878-884.
[9] 杨刚, 黄徐建, 朱建交, 熊永福, 李敬东. 两种不同类型肝门周围胆管癌临床病理特征及生存预后[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(06): 931-938.
[10] 吴刚, 严燃星, 严鑫, 阎婧, 何跃明, 朱倩. 基于血清和组织外泌体多组学分析筛选胰腺癌诊断和预后标志物[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(06): 962-972.
[11] 袁慧, 周芦忠, 汤鹤年, 潘菊花. LMR与PHR对射频消融术后肝细胞癌患者预后的评估[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(06): 635-641.
[12] 刘艳晶, 解祥军, 魏志. 术前丙氨酸氨基转移酶/天冬氨酸氨基转移酶比值与消化道肿瘤预后的关系[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(06): 655-660.
[13] 周懿, 黄容华, 刘政疆. 5-羟色胺与铁死亡介导的脓毒症心肌病的研究进展[J/OL]. 中华临床医师杂志(电子版), 2025, 19(08): 612-617.
[14] 高兴梅, 周洁容, 杨溢, 张孟祥, 张仲谋, 李斌. 重症肺炎患者血磷水平轨迹与短期预后之间的关系[J/OL]. 中华临床医师杂志(电子版), 2025, 19(07): 479-485.
[15] 宁雯琪, 张永利. 脓毒症心肌病的研究进展:基础、临床与展望[J/OL]. 中华临床医师杂志(电子版), 2025, 19(06): 461-466.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?